​
​

Deciphera Pharmaceuticals Ownership | Who Owns Deciphera Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Deciphera Pharmaceuticals Ownership Summary

Deciphera Pharmaceuticals is owned by 70.01% institutional investors, and 29.99% retail investors. Algert global is the largest institutional shareholder, holding 0% of DCPH shares. UBS: US Equity Small Cap Growth is the top mutual fund, with 1.12% of its assets in Deciphera Pharmaceuticals shares.

DCPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDeciphera Pharmaceuticals70.01%-29.99%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks33.38%9.20%57.42%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Algert global---
Price t rowe associates inc /md/---
Geode capital management---
Voya investment management---
Fisher asset management---
Proshare advisors---
Dana investment advisors---
Jupiter asset management---
Sunesis advisors---
Intrust bank na---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Algert global---
Price t rowe associates inc /md/---
Geode capital management---
Voya investment management---
Fisher asset management---
Proshare advisors---
Dana investment advisors---
Jupiter asset management---
Sunesis advisors---
Intrust bank na---

Top Buyers

HolderShares% AssetsChange
Rothschild investment---10.00
First horizon advisors---30.00
Parallel advisors---62.00
Farther finance advisors---74.00
Cwm---83.00

Top Sellers

HolderShares% AssetsChange
Blackrock---5.99M
Armistice capital---5.90M
Redmile group---5.30M
Deerfield management company, l.p. (series c)---5.13M
Vanguard group---4.57M

Sold Out

HolderChange
Rothschild investment-10.00
First horizon advisors-30.00
Parallel advisors-62.00
Farther finance advisors-74.00
Cwm-83.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20241777.27%59,551,8872.76%701.51%931.09%5310.42%
Dec 31, 20231653.77%57,953,4512.41%681.54%9222.67%48-12.73%
Sep 30, 20231598.16%56,588,4650.67%661.44%758.70%5527.91%
Jun 30, 2023147-2.65%56,212,961-3.13%671.38%69-16.87%43-
Mar 31, 2023151-0.66%58,028,09510.95%701.50%8313.70%43-12.24%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
UBS: US Equity Small Cap Growth968.92K1.12%-
Man GLG Event Driven Alternative IN USD552.28K0.64%136.57K
MEDICAL BioHealth EUR Acc391.10K0.45%-
Arbitrage R379.98K0.44%379.98K
Empower Small Cap Growth/Emerald SP148.39K0.17%-
Goldman Sachs Small Cp Val Insghts Instl103.83K0.12%-
NT R2000 Value Index Fund - NL100.24K0.12%-425.00
AltShares Merger Arbitrage ETF88.93K0.10%88.93K
Jupiter Merian Glb Eq AbsRet I USD Acc87.54K0.10%25.38K
Water Island Event-Driven Fund I60.51K0.07%60.51K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 16, 2024Sherman Matthew L EVP & Chief Medical OfficerSell$40.84K
Feb 16, 2024Kelly Thomas Patrick Chief Financial OfficerSell$47.01K
Feb 16, 2024Pitman Jama SVP, Chief Development OfficerSell$35.41K
Feb 16, 2024Martin Daniel C. Chief Commercial OfficerSell$35.41K
Jan 16, 2024Sherman Matthew L EVP & Chief Medical OfficerSell$35.23K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1-8
2023 Q4-12
2023 Q3--
2023 Q225

DCPH Ownership FAQ

Who Owns Deciphera Pharmaceuticals?

Deciphera Pharmaceuticals shareholders are primarily institutional investors at 70.01%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Deciphera Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 33.38%, which Deciphera Pharmaceuticals exceeds.

Who owns the most shares of Deciphera Pharmaceuticals?

Deciphera Pharmaceuticals’s largest shareholders are Algert global (0 shares, 0%), Price t rowe associates inc /md/ (0 shares, 0%), and Geode capital management (0 shares, 0%). Together, they hold 0% of Deciphera Pharmaceuticals’s total shares outstanding.

Does Blackrock own Deciphera Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Deciphera Pharmaceuticals.

Who is Deciphera Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Algert global is Deciphera Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Deciphera Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Deciphera Pharmaceuticals shares?

UBS: US Equity Small Cap Growth is the top mutual fund holder of Deciphera Pharmaceuticals shares, with 1.12% of its total shares outstanding invested in 968.92K Deciphera Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools